Sanegene Bio

Woburn, United States

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

$110.0M raised

Dec 2025

Series B

Top Investors

Qiming Venture PartnersShenzhen Capital GroupEli LillyLegend CapitalVivo Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Sanegene Bio raised?

Sanegene Bio has raised $110.0M in total funding. The most recent round was Series B. The last funding was announced in December 2025.

Who are Sanegene Bio's investors?

Sanegene Bio's investors include Qiming Venture Partners, Shenzhen Capital Group, Eli Lilly, Legend Capital, Vivo Capital.

Where is Sanegene Bio headquartered?

Sanegene Bio is headquartered in Woburn, United States.

What does Sanegene Bio do?

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

What stage is Sanegene Bio at?

Sanegene Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 8, 2025.

MLA

"Sanegene Bio — Funding & Investors." VCBacked, December 8, 2025, https://www.vcbacked.co/company/sanegene-bio. Accessed June 4, 2026.

APA

VCBacked. (2025). Sanegene Bio — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/sanegene-bio

Wikipedia (cite web)

{{cite web |title=Sanegene Bio — Funding & Investors |url=https://www.vcbacked.co/company/sanegene-bio |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 8, 2025.